Cargando…
Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option
Age-related macular degeneration (AMD) is a multifactorial disease, which can culminate in irreversible vision loss and blindness in elderly. Nowadays, there is a big gap between dry AMD and wet AMD on treatment. Accounting for nearly 90% of AMD, dry AMD still lacks effective treatment. Numerous gen...
Autores principales: | Qin, Shuqi, Dong, Ning, Yang, Ming, Wang, Jialin, Feng, Xue, Wang, Yanling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346298/ https://www.ncbi.nlm.nih.gov/pubmed/34368372 http://dx.doi.org/10.1155/2021/9945725 |
Ejemplares similares
-
Complement System and Potential Therapeutics in Age-Related Macular Degeneration
por: Park, Young Gun, et al.
Publicado: (2021) -
The complement system in age-related macular degeneration
por: Armento, Angela, et al.
Publicado: (2021) -
Systemic Complement Activation in Age-Related Macular Degeneration
por: Scholl, Hendrik P. N., et al.
Publicado: (2008) -
Complement factor I and age-related macular degeneration
por: Alexander, Philip, et al.
Publicado: (2014) -
“Complement-ary” Therapies for Age-Related Macular Degeneration
por: Lin, Jonathan B., et al.
Publicado: (2022)